883 related articles for article (PubMed ID: 9066659)
1. Enhancement of UV-A-induced cytotoxicity to cancer cell lines by camptothecin.
Kojima S; Fujishima H; Wang DS
Anticancer Res; 1997; 17(1A):241-6. PubMed ID: 9066659
[TBL] [Abstract][Full Text] [Related]
2. Radiosensitization of a mouse melanoma by withaferin A: in vivo studies.
Devi PU; Kamath R; Rao BS
Indian J Exp Biol; 2000 May; 38(5):432-7. PubMed ID: 11272405
[TBL] [Abstract][Full Text] [Related]
3. Enhancing potency of neopterin toward B-16 melanoma cell damage induced by UV-A irradiation and its possible application for skin tumor treatment.
Kojima S; Icho T; Mori H; Arai T
Anticancer Res; 1995; 15(5B):1975-80. PubMed ID: 8572587
[TBL] [Abstract][Full Text] [Related]
4. [Effect of etoposide on a human pancreatic cancer cell line exposed to high dose X-ray irradiation].
Mizumoto K; Tanaka M; Aramaki R
Gan To Kagaku Ryoho; 1996 Oct; 23(12):1673-5. PubMed ID: 8886042
[TBL] [Abstract][Full Text] [Related]
5. Elevated topoisomerase I activity in cervical cancer as a target for chemoradiation therapy.
Chen BM; Chen JY; Kao M; Lin JB; Yu MH; Roffler SR
Gynecol Oncol; 2000 Nov; 79(2):272-80. PubMed ID: 11063656
[TBL] [Abstract][Full Text] [Related]
6. Low-dose irradiation and short-exposure suboptimal-dose paclitaxel adversely modulate metastatic potential of squamous carcinoma cells.
Lövey J; Fazekas K; Ladányi A; Németh G; Tímár J
Strahlenther Onkol; 2003 Dec; 179(12):812-8. PubMed ID: 14652669
[TBL] [Abstract][Full Text] [Related]
7. Mammalian DNA topoisomerase I mediates the enhancement of radiation cytotoxicity by camptothecin derivatives.
Chen AY; Okunieff P; Pommier Y; Mitchell JB
Cancer Res; 1997 Apr; 57(8):1529-36. PubMed ID: 9108456
[TBL] [Abstract][Full Text] [Related]
8. A simple, informative, and quantitative flow cytometric method for assessing apoptosis in cultured cells.
Warrington RC; Norum JN; Hilchey JL; Watt C; Fang WD
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Apr; 27(2):231-43. PubMed ID: 12657362
[TBL] [Abstract][Full Text] [Related]
9. The tumour suppressor p33ING1 does not enhance camptothecin-induced cell death in melanoma cells.
Cheung KJ; Li G
Int J Oncol; 2002 Jun; 20(6):1319-22. PubMed ID: 12012016
[TBL] [Abstract][Full Text] [Related]
10. Replication-dependent and -independent camptothecin cytotoxicity of seven human colon tumor cell lines.
Borovitskaya AE; D'Arpa P
Oncol Res; 1998; 10(5):271-6. PubMed ID: 9802062
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells.
Masunaga S; Uto Y; Nagasawa H; Hori H; Nagata K; Suzuki M; Kinashi Y; Ono K
Anticancer Res; 2006; 26(2A):1261-70. PubMed ID: 16619533
[TBL] [Abstract][Full Text] [Related]
12. Preclinical studies of water-insoluble camptothecin congeners: cytotoxicity, development of resistance, and combination treatments.
Pantazis P
Clin Cancer Res; 1995 Nov; 1(11):1235-44. PubMed ID: 9815917
[TBL] [Abstract][Full Text] [Related]
13. Antiangiogenic effects of the novel camptothecin ST1481 (gimatecan) in human tumor xenografts.
Petrangolini G; Pratesi G; De Cesare M; Supino R; Pisano C; Marcellini M; Giordano V; Laccabue D; Lanzi C; Zunino F
Mol Cancer Res; 2003 Oct; 1(12):863-70. PubMed ID: 14573787
[TBL] [Abstract][Full Text] [Related]
14. Synergistic antitumor activity of troxacitabine and camptothecin in selected human cancer cell lines.
Kim TE; Park SY; Hsu CH; Dutschman GE; Cheng YC
Mol Pharmacol; 2004 Aug; 66(2):285-92. PubMed ID: 15266019
[TBL] [Abstract][Full Text] [Related]
15. DNA topoisomerase I content of a pair of human melanoma cell lines with very different radiosensitivities correlates with their in vitro sensitivities to camptothecin.
Ng CE; Cybulski SE; Bussey AM; Aubin RA; Raaphorst GP
Anticancer Res; 1998; 18(4C):3119-26. PubMed ID: 9713520
[TBL] [Abstract][Full Text] [Related]
16. Pattern of antitumor activity of a novel camptothecin, ST1481, in a large panel of human tumor xenografts.
Pratesi G; De Cesare M; Carenini N; Perego P; Righetti SC; Cucco C; Merlini L; Pisano C; Penco S; Carminati P; Vesci L; Zunino F
Clin Cancer Res; 2002 Dec; 8(12):3904-9. PubMed ID: 12473606
[TBL] [Abstract][Full Text] [Related]
17. Comparison of apoptotic, necrotic and clonogenic cell death and inhibition of cell growth following camptothecin and X-radiation treatment in a human melanoma and a human fibroblast cell line.
Quto b SS; Ng CE
Cancer Chemother Pharmacol; 2002 Feb; 49(2):167-75. PubMed ID: 11862432
[TBL] [Abstract][Full Text] [Related]
18. Enhanced phagemid particle gene transfer in camptothecin-treated carcinoma cells.
Burg MA; Jensen-Pergakes K; Gonzalez AM; Ravey P; Baird A; Larocca D
Cancer Res; 2002 Feb; 62(4):977-81. PubMed ID: 11861367
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of p53 increases the cytotoxicity of camptothecin in human colon HCT116 and breast MCF-7 cancer cells.
Gupta M; Fan S; Zhan Q; Kohn KW; O'Connor PM; Pommier Y
Clin Cancer Res; 1997 Sep; 3(9):1653-60. PubMed ID: 9815856
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial transmembrane potential in spontaneous and camptothecin-induced apoptosis of melanotic and amelanotic melanoma cells.
Cichorek M; Kozłowska K; Bryl E
Neoplasma; 2007; 54(1):29-36. PubMed ID: 17203890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
